Cargando…
Incidence, clinical course and risk factor for recurrent PCR positivity in discharged COVID-19 patients in Guangzhou, China: A prospective cohort study
The phenomenon of COVID-19 patients tested positive for SARS-CoV-2 after discharge (redetectable as positive, RP) emerged globally. The data of incidence rate and risk factors for RP event and the clinical features of RP patients may provide recommendations for virus containment and cases management...
Autores principales: | , , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7505432/ https://www.ncbi.nlm.nih.gov/pubmed/32866168 http://dx.doi.org/10.1371/journal.pntd.0008648 |
_version_ | 1783584810788192256 |
---|---|
author | Zheng, Jiazhen Zhou, Rui Chen, Fengjuan Tang, Guofang Wu, Keyi Li, Furong Liu, Huamin Lu, Jianyun Zhou, Jiyuan Yang, Ziying Yuan, Yuxin Lei, Chunliang Wu, Xianbo |
author_facet | Zheng, Jiazhen Zhou, Rui Chen, Fengjuan Tang, Guofang Wu, Keyi Li, Furong Liu, Huamin Lu, Jianyun Zhou, Jiyuan Yang, Ziying Yuan, Yuxin Lei, Chunliang Wu, Xianbo |
author_sort | Zheng, Jiazhen |
collection | PubMed |
description | The phenomenon of COVID-19 patients tested positive for SARS-CoV-2 after discharge (redetectable as positive, RP) emerged globally. The data of incidence rate and risk factors for RP event and the clinical features of RP patients may provide recommendations for virus containment and cases management for COVID-19. We prospectively collected and analyzed the epidemiological, clinical and virological data from 285 adult patients with COVID-19 and acquired their definite clinical outcome (getting PCR positive or not during post-discharge surveillance). By March 10, 27 (9.5%) discharged patients had tested positive for SARS-CoV-2 in their nasopharyngeal swab after a median duration of 7·0 days (IQR 5·0–8·0). Compared to first admission, RP patients generally had milder clinical symptoms, lower viral load, shorter length of stay and improved pulmonary conditions at readmission (p<0.05). Elder RP patients (≥ 60 years old) were more likely to be symptomatic compared to younger patients (7/8, 87.5% vs. 3/19, 18.8%, p = 0.001) at readmission. Age, sex, epidemiological history, clinical symptoms and underlying diseases were similar between RP and non-RP patients (p>0.05). A prolonged duration of viral shedding (>10 days) during the first hospitalization [adjusted odds ratio [aOR]: 5.82, 95% confidence interval [CI]: 2.50–13.57 for N gene; aOR: 9.64, 95% CI: 3.91–23.73 for ORF gene] and higher Ct value (ORF) in the third week of the first hospitalization (aOR: 0.69; 95% CI: 0.50–0.95) were associated with RP events. In conclusion, RP events occurred in nearly 10% of COVID-19 patients shortly after the negative tests, were not associated with worsening symptoms and unlikely reflect reinfection. Patients’ lack of efficiency in virus clearance was a risk factor for RP result. It is noteworthy that elder RP patients (≥ 60 years old) were more susceptible to clinical symptoms at readmission. |
format | Online Article Text |
id | pubmed-7505432 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2020 |
publisher | Public Library of Science |
record_format | MEDLINE/PubMed |
spelling | pubmed-75054322020-09-30 Incidence, clinical course and risk factor for recurrent PCR positivity in discharged COVID-19 patients in Guangzhou, China: A prospective cohort study Zheng, Jiazhen Zhou, Rui Chen, Fengjuan Tang, Guofang Wu, Keyi Li, Furong Liu, Huamin Lu, Jianyun Zhou, Jiyuan Yang, Ziying Yuan, Yuxin Lei, Chunliang Wu, Xianbo PLoS Negl Trop Dis Research Article The phenomenon of COVID-19 patients tested positive for SARS-CoV-2 after discharge (redetectable as positive, RP) emerged globally. The data of incidence rate and risk factors for RP event and the clinical features of RP patients may provide recommendations for virus containment and cases management for COVID-19. We prospectively collected and analyzed the epidemiological, clinical and virological data from 285 adult patients with COVID-19 and acquired their definite clinical outcome (getting PCR positive or not during post-discharge surveillance). By March 10, 27 (9.5%) discharged patients had tested positive for SARS-CoV-2 in their nasopharyngeal swab after a median duration of 7·0 days (IQR 5·0–8·0). Compared to first admission, RP patients generally had milder clinical symptoms, lower viral load, shorter length of stay and improved pulmonary conditions at readmission (p<0.05). Elder RP patients (≥ 60 years old) were more likely to be symptomatic compared to younger patients (7/8, 87.5% vs. 3/19, 18.8%, p = 0.001) at readmission. Age, sex, epidemiological history, clinical symptoms and underlying diseases were similar between RP and non-RP patients (p>0.05). A prolonged duration of viral shedding (>10 days) during the first hospitalization [adjusted odds ratio [aOR]: 5.82, 95% confidence interval [CI]: 2.50–13.57 for N gene; aOR: 9.64, 95% CI: 3.91–23.73 for ORF gene] and higher Ct value (ORF) in the third week of the first hospitalization (aOR: 0.69; 95% CI: 0.50–0.95) were associated with RP events. In conclusion, RP events occurred in nearly 10% of COVID-19 patients shortly after the negative tests, were not associated with worsening symptoms and unlikely reflect reinfection. Patients’ lack of efficiency in virus clearance was a risk factor for RP result. It is noteworthy that elder RP patients (≥ 60 years old) were more susceptible to clinical symptoms at readmission. Public Library of Science 2020-08-31 /pmc/articles/PMC7505432/ /pubmed/32866168 http://dx.doi.org/10.1371/journal.pntd.0008648 Text en © 2020 Zheng et al http://creativecommons.org/licenses/by/4.0/ This is an open access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0/) , which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited. |
spellingShingle | Research Article Zheng, Jiazhen Zhou, Rui Chen, Fengjuan Tang, Guofang Wu, Keyi Li, Furong Liu, Huamin Lu, Jianyun Zhou, Jiyuan Yang, Ziying Yuan, Yuxin Lei, Chunliang Wu, Xianbo Incidence, clinical course and risk factor for recurrent PCR positivity in discharged COVID-19 patients in Guangzhou, China: A prospective cohort study |
title | Incidence, clinical course and risk factor for recurrent PCR positivity in discharged COVID-19 patients in Guangzhou, China: A prospective cohort study |
title_full | Incidence, clinical course and risk factor for recurrent PCR positivity in discharged COVID-19 patients in Guangzhou, China: A prospective cohort study |
title_fullStr | Incidence, clinical course and risk factor for recurrent PCR positivity in discharged COVID-19 patients in Guangzhou, China: A prospective cohort study |
title_full_unstemmed | Incidence, clinical course and risk factor for recurrent PCR positivity in discharged COVID-19 patients in Guangzhou, China: A prospective cohort study |
title_short | Incidence, clinical course and risk factor for recurrent PCR positivity in discharged COVID-19 patients in Guangzhou, China: A prospective cohort study |
title_sort | incidence, clinical course and risk factor for recurrent pcr positivity in discharged covid-19 patients in guangzhou, china: a prospective cohort study |
topic | Research Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7505432/ https://www.ncbi.nlm.nih.gov/pubmed/32866168 http://dx.doi.org/10.1371/journal.pntd.0008648 |
work_keys_str_mv | AT zhengjiazhen incidenceclinicalcourseandriskfactorforrecurrentpcrpositivityindischargedcovid19patientsinguangzhouchinaaprospectivecohortstudy AT zhourui incidenceclinicalcourseandriskfactorforrecurrentpcrpositivityindischargedcovid19patientsinguangzhouchinaaprospectivecohortstudy AT chenfengjuan incidenceclinicalcourseandriskfactorforrecurrentpcrpositivityindischargedcovid19patientsinguangzhouchinaaprospectivecohortstudy AT tangguofang incidenceclinicalcourseandriskfactorforrecurrentpcrpositivityindischargedcovid19patientsinguangzhouchinaaprospectivecohortstudy AT wukeyi incidenceclinicalcourseandriskfactorforrecurrentpcrpositivityindischargedcovid19patientsinguangzhouchinaaprospectivecohortstudy AT lifurong incidenceclinicalcourseandriskfactorforrecurrentpcrpositivityindischargedcovid19patientsinguangzhouchinaaprospectivecohortstudy AT liuhuamin incidenceclinicalcourseandriskfactorforrecurrentpcrpositivityindischargedcovid19patientsinguangzhouchinaaprospectivecohortstudy AT lujianyun incidenceclinicalcourseandriskfactorforrecurrentpcrpositivityindischargedcovid19patientsinguangzhouchinaaprospectivecohortstudy AT zhoujiyuan incidenceclinicalcourseandriskfactorforrecurrentpcrpositivityindischargedcovid19patientsinguangzhouchinaaprospectivecohortstudy AT yangziying incidenceclinicalcourseandriskfactorforrecurrentpcrpositivityindischargedcovid19patientsinguangzhouchinaaprospectivecohortstudy AT yuanyuxin incidenceclinicalcourseandriskfactorforrecurrentpcrpositivityindischargedcovid19patientsinguangzhouchinaaprospectivecohortstudy AT leichunliang incidenceclinicalcourseandriskfactorforrecurrentpcrpositivityindischargedcovid19patientsinguangzhouchinaaprospectivecohortstudy AT wuxianbo incidenceclinicalcourseandriskfactorforrecurrentpcrpositivityindischargedcovid19patientsinguangzhouchinaaprospectivecohortstudy |